L. Piccari (Barcelona, Spain), L. JARA PALOMARES (Sevilla, Spain)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
An audit of adherence to Two-Level Well’s Score in patients hospitalized with Sars-Co-V-2 with suspected Pulmonary Emboli in a University Hospital. N. Boyle (Celbridge, Ireland), N. Nidonnaghain (Dublin, Ireland), E. Hunt (Dublin, Ireland)
|   |
Comparison of 3 prediction scores for diagnosis of Pulmonary Embolism S. Christopher (Vellore, India), R. Gupta (Vellore, India), B. Isaac (Vellore, India), D. Christopher (Vellore, India)
|   |
Compliance with BTS and NICE guidelines in assessment of possible pulmonary embolism A. Akhtar (Barnsley (South Yorkshire), United Kingdom), M. Usman (Barnsley (South Yorkshire), United Kingdom), H. Azam (Manchester, United Kingdom)
|   |
Pulmonary emboli and COVID-19: an increased risk for all? K. Mclaren (Edinburgh, United Kingdom), J. Tiernan (Edinburgh, United Kingdom), M. Pass (Edinburgh, United Kingdom), A. Lithgow (Edinburgh, United Kingdom), A. Mirchandani (Edinburgh, United Kingdom), V. Tilliridou (Edinburgh, United Kingdom), J. Anderson (Edinburgh, United Kingdom), A. Page (Edinburgh, United Kingdom), J. Murchison (Edinburgh, United Kingdom), R. Dickinson (Edinburgh, United Kingdom)
|   |
VTE in COVID-19 inpatients not receiving higher level care M. Carling (Newcastle, United Kingdom), A. Aujayeb (Newcastle, United Kingdom)
|   |
Elevated D-dimer and low ferritin may help predict pulmonary emboli in mild-moderate COVID-19 S. Ratnakumar (London, United Kingdom), P. Denniston (London, United Kingdom), M. Elliott (London, United Kingdom), D. Nair (London, United Kingdom), A. West (London, United Kingdom), S. Mak (London, United Kingdom)
|   |
Pulmonary embolism and COVID-19: a “special phenotype”? J. Lobo Beristain (Vitoria, Spain), J. Poyo Molina (Vitoria, Spain), S. Beltrán De Otálora García (Vitoria, Spain), S. García Fuika (Vitoria, Spain), B. Galaz Fernández (Vitoria, Spain), B. Lahidalga Múgica (Vitoria, Spain), M. Hurtado De Mendoza Rubio (Vitoria, Spain), M. Sánchez De Toro (Vitoria, Spain), P. Bordallo Vázquez (Vitoria, Spain), C. Ortega Michel (Vitoria, Spain), J. García Fuertes (Vitoria, Spain)
|   |
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia A. Sengül (Sakarya, Turkey), Y. Aydemir (Sakarya, Turkey), D. Özaydin (Ankara, Turkey), P. Akin Kabalak (Ankara, Turkey), Y. Söyler (Ankara, Turkey), H. Baykal (Ankara, Turkey), M. Turan (Izmir, Turkey), E. Alkilinç (Sinop, Turkey), F. Bozkus (Kahramanmaras, Turkey), P. Yildiz Gülhan (Düzce, Turkey), C. Satici (Istanbul, Turkey), S. Arslan (Çorum, Turkey), M. Demirkol (Istanbul, Turkey), N. Fazlioglu (Tekirdag, Turkey), A. Çapraz (Tekirdag, Turkey), P. Mutlu (Tekirdag, Turkey)
|   |
Pulmonary embolism in COVID-19 pneumonia patients: analysis from a dedicated outpatient setting post-hospitalization A. da Silva Alfaiate (Lisboa, Portugal), D. Noivo (Lisboa, Portugal), V. Clérigo (Lisboa, Portugal), M. Silva (Lisboa, Portugal), P. Duarte (Lisboa, Portugal)
|   |
Prevalence and characteristics of venous thromboembolism in severe exacerbation of COPD in a tertiary care hospital in India S. Meitei (Rishikesh (Uttarakhand), India), S. Tale (Rishikesh (Uttarakhand), India), A. Negi (Rishikesh (Uttarakhand), India), R. Dua (Rishikesh (Uttarakhand), India), R. Walia (Rishikesh (Uttarakhand), India), S. Saxena (Rishikesh (Uttarakhand), India)
|  |
Hemorrhagic complications in patients with COVID-19. Are they unusual? J. Lobo Beristain (Vitoria, Spain), I. Elorza Sagasta (Vitoria, Spain), A. Pereda Vicandi (Vitoria, Spain), J. Portu Zapirain (Vitoria, Spain), M. Hernandez Lopez (Vitoria, Spain), J. Redrado Ruiz (Vitoria, Spain), P. Oliva (Vitoria, Spain), I. Murga Arizabaleta (Vitoria, Spain), M. Sanchez De Toro (Vitoria, Spain), J. Poyo Molina (Vitoria, Spain), C. Ortega Michel (Vitoria, Spain), J. Garcia Fuertes (Vitoria, Spain)
|   |
Covid-19 and pulmonary embolism : A heterogeneous association K. Bahri (Tunis, Tunisia), S. Mhamdi (Tunis, Tunisia), S. Daboussi (Tunis, Tunisia), A. Riahi (Tunis, Tunisia), I. Yousfi (Tunis, Tunisia), I. Mejri (Tunis, Tunisia), C. Aichaouia (Tunis, Tunisia), Z. Moatamri (Tunis, Tunisia), M. Khadhraoui (Tunis, Tunisia)
|  |
Predictors and prognostic factors in a large Pulmonary embolism series S. Christopher (Vellore, India), R. Gupta (Vellore, India), B. Isaac (Vellore, India), D. Christopher (Vellore, India)
|   |
Biomarkers model for prediction of hospitalisation duration and pulmonary embolism outcome C. Kyriakopoulos (Ioannina, Greece), K. Bartziokas (Ioannina, Greece), A. Gogali (Ioannina, Greece), K. Tatsis (Ioannina, Greece), C. Chronis (Ioannina, Greece), D. Potonos (Ioannina, Greece), G. Gkrepi (Ioannina, Greece), K. Kostikas (Ioannina, Greece)
|   |
Should cancer be removed from sPESI score? M. Bugra Coskuner (Aksaray, Turkey), Y. Bülbül (Trabzon, Turkey), F. Öztuna (Trabzon, Turkey), T. Ozlu (Trabzon, Turkey)
|  |
10 year retrospective audit from Ambulatory Pulmonary embolism pathway in a tertiary hospital R. Sudhir (Leicester (Leicestershire), United Kingdom), E. Bailie (Leicester (Leicestershire), United Kingdom), N. Parmar (Leicester (Leicestershire), United Kingdom)
|  |
Follow-up of acute pulmonary embolism (PE): need for dedicated PE clinics and multidisciplinary team (MDT) meetings? V. Oakden (Stoke-on-Trent , United Kingdom), R. Cooper (Stoke-on-Trent , United Kingdom), S. Lim (Stoke-on-Trent , United Kingdom), M. Inani (Stoke-on-Trent , United Kingdom), R. Jameel (Stoke-on-Trent , United Kingdom), T. Waseem (Stoke-on-Trent , United Kingdom), M. Zahran (Stoke-on-Trent , United Kingdom), Z. Isiaka (Stoke-on-Trent , United Kingdom), M. Ganaie (Stoke-on-Trent , United Kingdom)
|   |
Histology of lung cancer and pulmonary embolism. Are they related? A. Martinez Mesa (Malaga, Spain), E. Cabrera Cesar (Malaga, Spain), E. Sanchez Alvarez (Malaga, Spain), L. Piñel Jimenez (Malaga, Spain), A. Aguilar Alvarez (Malaga, Spain), N. Reina Marfil (Malaga, Spain)
|   |
Pulmonary embolism in patients with seasonal influenza: a single centre retrospective review. S. Ekhelikar (Stoke-on-Trent (Staffordshire), United Kingdom), A. Kodamanchile (Stoke-on-Trent (Staffordshire), United Kingdom), A. Muthusami (Stoke-on-Trent (Staffordshire), United Kingdom), B. Baburaj (Stoke-on-Trent (Staffordshire), United Kingdom), S. Bikmalla (Stoke-on-Trent (Staffordshire), United Kingdom)
|   |
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism A. Çimen (istanbul, Turkey), A. Kalpaklioglu (kirikkale, Turkey)
|  |